Crystalys Therapeutics
Clinical trials sponsored by Crystalys Therapeutics, explained in plain language.
-
New hope for gout sufferers: experimental drug dotinurad enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called dotinurad for adults with gout who cannot take common medications or did not respond to other treatments. The goal is to see if dotinurad can safely lower uric acid levels over 24 weeks. About 90 participants will receive either the drug or a pl…
Phase: PHASE2 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New gout drug aims to beat allopurinol in major trial
Disease control Recruiting nowThis study tests a new medicine called dotinurad to see if it lowers uric acid better than the standard drug allopurinol in adults with gout. About 500 people with frequent gout flares will take either dotinurad or allopurinol for 24 weeks. The main goal is to see how many reach …
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New gout drug aims to dissolve painful joint crystals
Disease control Recruiting nowThis study tests a new drug called dotinurad against the standard gout medicine allopurinol in 250 adults with tophaceous gout (gout with visible lumps under the skin). The main goal is to see if dotinurad lowers uric acid levels more effectively after 24 weeks. Participants will…
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:38 UTC